Md Meraj Anjum

Md Meraj Anjum, PhD, is a Research Fellow in the Department of Pharmaceutical Sciences and Experimental Therapeutics at the University of Iowa's College of Pharmacy. His work focuses on advanced drug delivery systems, particularly nanoparticles and biomaterials for therapeutic applications. He specializes in developing formulations targeting wound healing, antimicrobial resistance, and cancer therapies.

His research integrates nanotechnology with pharmaceutical sciences to address challenges in drug solubility, bioavailability, and targeted delivery. Key areas include electrospun nanofibers for burn repair, lipid-based nanoparticles for cystic fibrosis treatment, and phage-loaded microparticles for multidrug-resistant infections.

Dr. Anjum’s articles highlight trends in synergistic drug combinations, biofilm disruption strategies, and theranostic applications of metallic nanoparticles. His work emphasizes translational research with potential clinical impact in dermatology, oncology, and cardiovascular health. Though no awards or grants are explicitly listed, his prolific publication record demonstrates active engagement in cutting-edge biomedical research.

His current studies explore innovative delivery systems such as collagen-enriched nanofibers, niosomes for cardioprotection, and cyclodextrin-crosslinked nanosponges. These efforts aim to enhance treatment efficacy while minimizing systemic toxicity.